Kenneth Krogulski J.'s most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 80 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.74 per share. | 02 Jun 2025 | 80 | 286,633 (1%) | 0% | 2.7 | 219 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.20 per share. | 02 Jun 2025 | 45 | 285,743 (1%) | 0% | 5.2 | 234 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 02 Jun 2025 | 45 | 286,553 (1%) | 0% | 2.6 | 117 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.71 per share. | 02 Jun 2025 | 45 | 286,508 (1%) | 0% | 2.7 | 122 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.27 per share. | 02 Jun 2025 | 45 | 286,463 (1%) | 0% | 3.3 | 147 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 3.91 per share. | 02 Jun 2025 | 45 | 286,418 (1%) | 0% | 3.9 | 176 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 02 Jun 2025 | 45 | 286,373 (1%) | 0% | 4.6 | 207 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 02 Jun 2025 | 45 | 286,328 (1%) | 0% | 5.3 | 238 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.51 per share. | 02 Jun 2025 | 45 | 286,283 (1%) | 0% | 5.5 | 248 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 02 Jun 2025 | 45 | 286,238 (1%) | 0% | 5.6 | 252 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 02 Jun 2025 | 45 | 286,193 (1%) | 0% | 5.3 | 239 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.80 per share. | 02 Jun 2025 | 45 | 286,148 (1%) | 0% | 5.8 | 261 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.67 per share. | 02 Jun 2025 | 45 | 286,103 (1%) | 0% | 5.7 | 255 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.58 per share. | 02 Jun 2025 | 45 | 286,058 (1%) | 0% | 5.6 | 251 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 02 Jun 2025 | 45 | 286,013 (1%) | 0% | 6 | 270 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.93 per share. | 02 Jun 2025 | 45 | 285,968 (1%) | 0% | 5.9 | 267 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.58 per share. | 02 Jun 2025 | 45 | 285,923 (1%) | 0% | 5.6 | 251 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.47 per share. | 02 Jun 2025 | 45 | 285,878 (1%) | 0% | 5.5 | 246 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.76 per share. | 02 Jun 2025 | 45 | 285,833 (1%) | 0% | 5.8 | 259 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 02 Jun 2025 | 45 | 285,788 (1%) | 0% | 5.6 | 252 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.78 per share. | 01 May 2025 | 45 | 285,068 (1%) | 0% | 4.8 | 215 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.93 per share. | 01 May 2025 | 45 | 285,698 (1%) | 0% | 4.9 | 222 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.67 per share. | 01 May 2025 | 45 | 285,653 (1%) | 0% | 5.7 | 255 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 01 May 2025 | 45 | 285,608 (1%) | 0% | 5.7 | 256 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.27 per share. | 01 May 2025 | 45 | 285,563 (1%) | 0% | 5.3 | 237 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.13 per share. | 01 May 2025 | 45 | 285,518 (1%) | 0% | 5.1 | 231 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 01 May 2025 | 45 | 285,473 (1%) | 0% | 5.1 | 230 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 01 May 2025 | 45 | 285,428 (1%) | 0% | 5.0 | 227 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 01 May 2025 | 45 | 285,383 (1%) | 0% | 5.4 | 243 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.91 per share. | 01 May 2025 | 45 | 285,338 (1%) | 0% | 4.9 | 221 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 01 May 2025 | 45 | 285,293 (1%) | 0% | 5.4 | 242 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.20 per share. | 01 May 2025 | 45 | 285,248 (1%) | 0% | 5.2 | 234 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 01 May 2025 | 45 | 285,203 (1%) | 0% | 5.7 | 256 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.67 per share. | 01 May 2025 | 45 | 285,158 (1%) | 0% | 5.7 | 255 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.24 per share. | 01 May 2025 | 45 | 285,113 (1%) | 0% | 5.2 | 236 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.51 per share. | 01 May 2025 | 45 | 285,023 (1%) | 0% | 4.5 | 203 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.71 per share. | 01 May 2025 | 45 | 284,978 (1%) | 0% | 4.7 | 212 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 01 May 2025 | 45 | 284,933 (1%) | 0% | 4.6 | 207 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.69 per share. | 01 May 2025 | 45 | 284,888 (1%) | 0% | 4.7 | 211 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 01 May 2025 | 45 | 284,843 (1%) | 0% | 4.8 | 214 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.87 per share. | 01 May 2025 | 45 | 284,798 (1%) | 0% | 4.9 | 219 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.78 per share. | 01 Apr 2025 | 55 | 284,398 (1%) | 0% | 4.8 | 263 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.62 per share. | 01 Apr 2025 | 55 | 284,343 (1%) | 0% | 4.6 | 254 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 01 Apr 2025 | 55 | 284,288 (1%) | 0% | 4.2 | 233 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 01 Apr 2025 | 55 | 284,233 (1%) | 0% | 4.1 | 228 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 01 Apr 2025 | 55 | 284,178 (1%) | 0% | 4.0 | 222 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.95 per share. | 01 Apr 2025 | 55 | 284,618 (1%) | 0% | 4.9 | 272 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.13 per share. | 01 Apr 2025 | 55 | 284,563 (1%) | 0% | 5.1 | 282 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.02 per share. | 01 Apr 2025 | 55 | 284,508 (1%) | 0% | 5.0 | 276 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 01 Apr 2025 | 55 | 284,453 (1%) | 0% | 4.7 | 261 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 01 Apr 2025 | 45 | 283,763 (1%) | 0% | 4.2 | 191 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.02 per share. | 01 Apr 2025 | 45 | 284,123 (1%) | 0% | 4.0 | 181 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Apr 2025 | 45 | 284,078 (1%) | 0% | 4 | 180 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.09 per share. | 01 Apr 2025 | 45 | 284,033 (1%) | 0% | 4.1 | 184 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.13 per share. | 01 Apr 2025 | 45 | 283,988 (1%) | 0% | 4.1 | 186 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 01 Apr 2025 | 45 | 283,943 (1%) | 0% | 4.2 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.22 per share. | 01 Apr 2025 | 45 | 283,898 (1%) | 0% | 4.2 | 190 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 01 Apr 2025 | 45 | 283,853 (1%) | 0% | 4.2 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.40 per share. | 01 Apr 2025 | 45 | 283,808 (1%) | 0% | 4.4 | 198 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.80 per share. | 01 Apr 2025 | 45 | 284,753 (1%) | 0% | 4.8 | 216 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.93 per share. | 01 Apr 2025 | 45 | 284,708 (1%) | 0% | 4.9 | 222 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.91 per share. | 01 Apr 2025 | 45 | 284,663 (1%) | 0% | 4.9 | 221 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 17 Mar 2025 | 4,000 | 282,843 (1%) | 0% | 5.2 | 20,680 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 17 Mar 2025 | 1,000 | 278,843 (1%) | 0% | 5.2 | 5,170 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 03 Mar 2025 | 47 | 282,937 (1%) | 0% | 5.1 | 240 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 6.74 per share. | 03 Mar 2025 | 47 | 282,984 (1%) | 0% | 6.7 | 317 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 6.57 per share. | 03 Mar 2025 | 47 | 283,031 (1%) | 0% | 6.6 | 309 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 6.51 per share. | 03 Mar 2025 | 47 | 283,078 (1%) | 0% | 6.5 | 306 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.53 per share. | 03 Mar 2025 | 47 | 282,890 (1%) | 0% | 5.5 | 260 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.29 per share. | 03 Mar 2025 | 45 | 283,718 (1%) | 0% | 4.3 | 193 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.42 per share. | 03 Mar 2025 | 45 | 283,493 (1%) | 0% | 4.4 | 199 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.44 per share. | 03 Mar 2025 | 45 | 283,538 (1%) | 0% | 4.4 | 200 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.40 per share. | 03 Mar 2025 | 45 | 283,583 (1%) | 0% | 4.4 | 198 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 03 Mar 2025 | 45 | 283,628 (1%) | 0% | 4.2 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 03 Mar 2025 | 45 | 283,673 (1%) | 0% | 4.2 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.84 per share. | 03 Mar 2025 | 37 | 283,115 (1%) | 0% | 5.8 | 216 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 03 Mar 2025 | 37 | 283,152 (1%) | 0% | 4.8 | 179 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.16 per share. | 03 Mar 2025 | 37 | 283,189 (1%) | 0% | 5.2 | 191 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.46 per share. | 03 Mar 2025 | 37 | 283,226 (1%) | 0% | 5.5 | 202 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 03 Mar 2025 | 37 | 283,263 (1%) | 0% | 5.4 | 199 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.41 per share. | 03 Mar 2025 | 37 | 283,300 (1%) | 0% | 5.4 | 200 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 03 Mar 2025 | 37 | 283,337 (1%) | 0% | 5.1 | 189 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.41 per share. | 03 Mar 2025 | 37 | 283,374 (1%) | 0% | 5.4 | 200 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 03 Mar 2025 | 37 | 283,411 (1%) | 0% | 5.1 | 188 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 4.89 per share. | 03 Mar 2025 | 37 | 283,448 (1%) | 0% | 4.9 | 181 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 02 Dec 2024 | 415 | 272,457 (1%) | 0% | 1.3 | 523 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 02 Dec 2024 | 415 | 272,042 (1%) | 0% | 1.3 | 552 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 02 Dec 2024 | 415 | 273,637 (1%) | 0% | 1.2 | 498 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 02 Dec 2024 | 415 | 272,872 (1%) | 0% | 1.2 | 506 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 02 Dec 2024 | 415 | 274,052 (1%) | 0% | 1.3 | 519 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 02 Dec 2024 | 350 | 273,222 (1%) | 0% | 1.2 | 420 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 02 Dec 2024 | 312 | 275,776 (1%) | 0% | 2.2 | 683 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth J. Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 02 Dec 2024 | 312 | 275,152 (1%) | 0% | 2.2 | 690 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 02 Dec 2024 | 312 | 275,464 (1%) | 0% | 2.1 | 661 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 02 Dec 2024 | 301 | 276,343 (1%) | 0% | 2.3 | 707 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 2.33 per share. | 02 Dec 2024 | 266 | 276,042 (1%) | 0% | 2.3 | 620 | Common Stock |
| Cumberland Pharmaceuticals... | Kenneth Krogulski J. | Director | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 02 Dec 2024 | 197 | 274,446 (1%) | 0% | 2.3 | 451 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski J. Kenneth | Director | Purchase of securities on an exchange or from another person at price $ 2.33 per share. | 02 Dec 2024 | 197 | 274,840 (1%) | 0% | 2.3 | 459 | Common Stock |
| Cumberland Pharmaceuticals... | Krogulski Kenneth J. | Director | Purchase of securities on an exchange or from another person at price $ 2.48 per share. | 02 Dec 2024 | 197 | 274,249 (1%) | 0% | 2.5 | 489 | Common Stock |
| Cumberland Pharmaceuticals... | J. Kenneth Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 02 Dec 2024 | 197 | 274,643 (1%) | 0% | 2.2 | 431 | Common Stock |
| Cumberland Pharmaceuticals... | J. Kenneth Krogulski | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 01 Nov 2024 | 474 | 271,627 (1%) | 0% | 1.3 | 626 | Common Stock |